Fundz

Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer

PUBLIC · KLRAAug 11, 2026
New to company · from Apellis Pharmaceuticals“She previously served as Chief Technical Operations Officer at Apellis Pharmaceuticals”

Position

Chief Technology Officer

Company

Kailera Therapeutics

Nur Nicholson
WalthamBiotechnologyHealth Care

Description

Kailera Therapeutics has announced the appointment of Nur Nicholson as Chief Technology Officer, effective August 31, 2026. Nur brings nearly three decades of experience in technical operations and manufacturing, which will be crucial as the company advances its obesity pipeline towards commercialization.

Quick answer

Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer (August 11, 2026). Kailera Therapeutics is based in Waltham, Massachusetts, United States.

Who is the new Chief Technology Officer at Kailera Therapeutics?
Kailera Therapeutics named Nur Nicholson Chief Technology Officer, announced August 11, 2026.
What did Kailera Therapeutics announce on August 11, 2026?
Kailera Therapeutics has announced the appointment of Nur Nicholson as Chief Technology Officer, effective August 31, 2026. Nur brings nearly three decades of experience in technical operations and manufacturing, which will be crucial as the company advances its obesity pipeline towards commercialization.
Where did Nur Nicholson work before joining Kailera Therapeutics?
Nur Nicholson joins from Apellis Pharmaceuticals.
What does Kailera Therapeutics do?
Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity.
Where is Kailera Therapeutics based?
Kailera Therapeutics is based in Waltham, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Versa Vascular (August 11, 2026), Quantitative Biosciences Institute (August 11, 2026), City Therapeutics (August 11, 2026) and Kalohexis (August 11, 2026) also announced leadership changes within 45 days of Kailera Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kailera Therapeutics, and when

A new leader at Kailera Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kailera Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kailera Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kailera Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kailera Therapeutics

Location

180 Third Ave 4th Floor

Waltham, Massachusetts, United States

About

Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive clinical trial results in obesity in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kailera Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ron
Senior decision-maker at this company
••••••••@••••••••

See Ron's verified email →

Douglas
Senior decision-maker at this company
••••••••@••••••••

See Douglas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kailera Therapeutics's next move

Learn about Strategic plan

Kailera Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.